Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:EDNMYOTCMKTS:HNLGYOTCMKTS:PALAFOTCMKTS:SWTUY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEDNMYEdenred$14.95-6.6%$15.92$14.00▼$24.00$7.17B0.768,847 shs7,536 shsHNLGYHang Lung Group$8.13+11.4%$7.03$5.28▼$8.13$7.32B0.1315 shs365 shsPALAFPaladin Energy$4.30+1.4%$3.67$2.33▼$10.53$1.72B1.71177,055 shs110,515 shsSWTUYSWEDISH ORPHAN/S$24.38-1.2%$24.38$18.50▼$31.96$6.64B1.811,665 shs200 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEDNMYEdenred0.00%-0.33%-0.33%-16.71%-36.92%HNLGYHang Lung Group0.00%+11.37%+16.14%+17.91%+43.01%PALAFPaladin Energy0.00%+4.88%+6.44%+5.25%-55.65%SWTUYSWEDISH ORPHAN/S0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEDNMYEdenredN/AN/AN/AN/AN/AN/AN/AN/AHNLGYHang Lung GroupN/AN/AN/AN/AN/AN/AN/AN/APALAFPaladin Energy0.5915 of 5 stars0.01.00.00.02.40.01.9SWTUYSWEDISH ORPHAN/SN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEDNMYEdenred 2.00HoldN/AN/AHNLGYHang Lung Group 0.00N/AN/AN/APALAFPaladin Energy 2.00HoldN/AN/ASWTUYSWEDISH ORPHAN/S 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest PALAF, EDNMY, SWTUY, and HNLGY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/14/2025PALAFPaladin EnergyRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold3/26/2025PALAFPaladin EnergyJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeHold(Data available from 6/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEDNMYEdenred$3.09B2.32$1.07 per share14.00N/A∞HNLGYHang Lung Group$1.51B4.85$0.50 per share16.12$20.09 per share0.40PALAFPaladin Energy$4.70M364.96N/AN/A$1.33 per share3.23SWTUYSWEDISH ORPHAN/S$763.19M8.71$0.70 per share34.66$2.88 per share8.47Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEDNMYEdenred$288.95MN/A0.0010.990.63N/AN/AN/A7/23/2025 (Estimated)HNLGYHang Lung Group$276.02MN/A0.00∞N/AN/AN/AN/A7/28/2025 (Estimated)PALAFPaladin Energy$53.63MN/A0.0014.83N/AN/AN/AN/AN/ASWTUYSWEDISH ORPHAN/S$134.73M$0.5048.7616.931.3025.75%29.63%18.74%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEDNMYEdenred$0.442.94%N/AN/AN/AHNLGYHang Lung Group$0.799.72%N/AN/AN/APALAFPaladin EnergyN/AN/AN/AN/AN/ASWTUYSWEDISH ORPHAN/SN/AN/AN/AN/AN/ALatest PALAF, EDNMY, SWTUY, and HNLGY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/3/2025EDNMYEdenred$0.49903.18%6/9/20256/10/20256/27/20255/2/2025HNLGYHang Lung Group$0.39917.39%5/8/20255/9/20256/26/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEDNMYEdenredN/A0.840.78HNLGYHang Lung Group0.340.71N/APALAFPaladin Energy0.344.021.50SWTUYSWEDISH ORPHAN/SN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEDNMYEdenredN/AHNLGYHang Lung GroupN/APALAFPaladin Energy0.01%SWTUYSWEDISH ORPHAN/SN/AInsider OwnershipCompanyInsider OwnershipEDNMYEdenredN/AHNLGYHang Lung GroupN/APALAFPaladin EnergyN/ASWTUYSWEDISH ORPHAN/SN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEDNMYEdenred12,000479.78 millionN/ANot OptionableHNLGYHang Lung Group4,200899.85 millionN/ANot OptionablePALAFPaladin Energy307398.91 millionN/ANot OptionableSWTUYSWEDISH ORPHAN/S902272.51 millionN/ANot OptionablePALAF, EDNMY, SWTUY, and HNLGY HeadlinesRecent News About These CompaniesSwedish Orphan Biovitrum AB: Sobi and Apellis: Aspaveli/Empaveli Demonstrates Sustained One-Year Efficacy in Phase 3 Study for Rare Kidney DiseasesJune 6, 2025 | finanznachrichten.deSwedish health minister pressed to fund orphan drug accessMay 30, 2025 | euractiv.comSwedish Orphan Biovitrum AB: Sobi to share new clinical data and research at EULAR 2025May 28, 2025 | finanznachrichten.deBerenberg cuts SOBI stock target to SEK360, maintains buyApril 18, 2025 | uk.investing.comSobi announces a new research collaboration on the development of Gamifant in sepsis, which is to be presented at the ISICEM congressMarch 21, 2025 | pharmabiz.comRBC Capital Remains a Buy on Swedish Orphan Biovitrum AB (0MTD)January 14, 2025 | markets.businessinsider.comSobi Announces FDA Acceptance of New Drug Application for Avatrombopag (DOPTELET®) for the Treatment of Pediatric Immune ThrombocytopeniaDecember 12, 2024 | markets.businessinsider.comSobi North America Says SNDA Accepted For Avatrombopag In Paediatric Immune ThrombocytopeniaDecember 12, 2024 | markets.businessinsider.comLarger Study Supports Safety of Tetracyclines During Early PregnancyNovember 14, 2024 | medpagetoday.comSobi to present new data across its immunology portfolio at the ACR Convergence 2024November 7, 2024 | finance.yahoo.comSwedish Orphan Biovitrum AB: Sobi Q3 2024 report: Strong growth and significant pipeline momentumOctober 24, 2024 | finanznachrichten.deSobi Q3 2024 report: Strong growth and significant pipeline momentumOctober 24, 2024 | finance.yahoo.comMerck Virus Treatment Shows 60.4% Effectiveness, Reduces Certain Infections In InfantsOctober 18, 2024 | benzinga.comMerck's RSV antibody for infants effective in reducing some types of infections in study (Oct 17)October 18, 2024 | msn.comHigh Growth Tech Stocks In Sweden With Promising PotentialOctober 17, 2024 | finance.yahoo.comMerck's RSV antibody for infants shows over 60% efficacy in mid-late-stage studyOctober 17, 2024 | reuters.comThe Swedish Royal Family and Its Members, ExplainedOctober 9, 2024 | vogue.comExploring Sweden's High Growth Tech GiantsOctober 2, 2024 | uk.finance.yahoo.comNew Swedish law enables government funding for babysitting grandparentsSeptember 27, 2024 | yahoo.comEurope's CHMP turns down Apellis' pegcetacoplan appeal, endorses new drugs from Pfizer, ImmunoGen and HenliusSeptember 20, 2024 | fiercepharma.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePALAF, EDNMY, SWTUY, and HNLGY Company DescriptionsEdenred OTCMKTS:EDNMY$14.95 -1.05 (-6.56%) As of 06/13/2025 02:51 PM EasternEdenred SE provides digital platform for services and payments for companies, employees, and merchants worldwide. It offers employee benefit solutions, including Ticket Restaurant, a solution that allows employees to take time out for lunch at a partner merchant; Ticket Alimentación that allows users to pay for groceries in neighborhood stores and supermarkets; Ticket Regalo, a gift voucher; Ticket CESU, a human services solution; Ticket Plus Card, a solution that enables the purchase of staples, such as food and fuel; Ticket Welfare, which employees can use to pay for a range of services, such as access to sports facilities and solutions for their children's educational needs; Ticket Guardería for companies without on-site daycare facilities; Childcare Vouchers; Ticket EcoCheque, a solutions that encourages purchase of environmentally friendly products; Ticket Kadeos Culture and Ticket Cultura that are solutions for cultural goods and services. The company also offers mobility solutions comprising Ticket Log for light vehicle fleet management; Ticket Fleet Pro and Ticket Cargo for truck fleet management; Ticket Car for employees to pay for fuel and other business travel expenses; UTA Edenred for paying tolls, optimize routes, pay for roadside assistance and truck servicing, and for VAT reimbursement; fuel cards; and refund services for VAT and excise duties. In addition, it provides complementary solutions comprising corporate payment, invoice processing automation, and salary card solutions. Edenred SE was founded in 1962 and is headquartered in Issy-les-Moulineaux, France.Hang Lung Group OTCMKTS:HNLGY$8.13 +0.83 (+11.37%) As of 06/13/2025 11:26 AM EasternHang Lung Group Limited, an investment holding company, operates as a property developer in Hong Kong and the Mainland of China. The company operates through Property Leasing and Property Sales segments. It develops properties for sale and lease, such as large-scale commercial, office, and residential developments. The company also invests in and develops various properties, including shopping malls, office premises, residential and industrial premises, and car parking bays. In addition, its investment properties portfolio includes Grand Gateway 66, a commercial, office, and residential complex, as well as Plaza 66, a commercial and office complex in Shanghai; Palace 66 and Forum 66 in Shenyang; Parc 66 in Jinan; Center 66 in Wuxi; Riverside 66 in Tianjin; Olympia 66 in Dalian; Spring City 66 in Kunming; and Heartland 66 in Wuhan. Further, the company offers car park and property management, financial, management, project management, and property agency services, as well as operates and manages apartment. Hang Lung Group Limited was incorporated in 1960 and is headquartered in Central, Hong Kong.Paladin Energy OTCMKTS:PALAF$4.30 +0.06 (+1.42%) As of 06/13/2025 03:57 PM EasternPaladin Energy Ltd develops, explores for, owns, and operates uranium mines in Australia, Canada, and Africa. The company operates through Exploration, Namibia, and Australia segments. Its flagship project is the Langer Heinrich mine located in the Namib Desert in Namibia. The company was formerly known as Paladin Resources Ltd and changed its name to Paladin Energy Limited in November 2007. Paladin Energy Ltd was incorporated in 1993 and is headquartered in Perth, Australia.SWEDISH ORPHAN/S OTCMKTS:SWTUY$24.38 -0.29 (-1.18%) As of 04/9/2019Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B. It also provides Orfadin for the treatment of hereditary tyrosinaemia type 1; and Kineret for the treatment of auto inflammatory condition, as well as Xiapex to treat Dupuytren's contracture and Peyronie's disease. In addition, the company manufactures drug substance for ReFacto AF; and develops BIVV001 and BIVV002 for the treatment of hemophilia. It operates in Sweden, the Middle East, North Africa, Russia, North America, other European countries, and internationally. The company has an agreement with Bioverativ for the development and commercialization of Elocta and Alprolix, as well as XTEN-programs. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Alphabet Enters a Bull Market: Is It Time to Buy? Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones RH Stock Rockets on Surprise Profit and Tariff Shift Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
